Diadema Partners »

Spruce Biosciences shares owned by Diadema Partners

Quarter-by-quarter ownership of Spruce Biosciences (SPRB) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Spruce Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Spruce Biosciences held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spruce Biosciences by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $654k 10k 65.35

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Spruce Biosciences

Ikarian Capital
Millennium Management
Citadel Advisors
ADAR1 Capital Management
Alyeska Investment Group
Wellington Management Company
Boothbay Fund Management
Balyasny Asset Management
Carlyle
Quinn Opportunity Partners
Vanguard Group
BlackRock
Geode Capital Management
Squadron Capital Management
Diadema Partners

View all funds holding Spruce Biosciences